ClinicalTrials.gov record
Completed Phase 3 Interventional

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

ClinicalTrials.gov ID: NCT00002812

Public ClinicalTrials.gov record NCT00002812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study

Study identification

NCT ID
NCT00002812
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Children's Oncology Group
Network
Enrollment
2,078 participants

Conditions and interventions

Conditions

Interventions

  • asparaginase Drug
  • cyclophosphamide Drug
  • cytarabine Drug
  • daunorubicin hydrochloride Drug
  • dexamethasone Drug
  • doxorubicin hydrochloride Drug
  • idarubicin Drug
  • mercaptopurine Drug
  • methotrexate Drug
  • pegaspargase Drug
  • prednisone Drug
  • radiation therapy Radiation
  • thioguanine Drug
  • vincristine sulfate Drug

Drug · Radiation

Eligibility (public fields only)

Age range
1 Year to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 1996
Primary completion
Feb 28, 2006
Completion
Not listed
Last update posted
Aug 25, 2013

Started 1996

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Long Beach Memorial Medical Center Long Beach California 90806
Children's Hospital Los Angeles Los Angeles California 90027-0700
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Children's Hospital of Orange County Orange California 92868
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128
Children's Hospital of Denver Denver Colorado 80218
Children's National Medical Center Washington D.C. District of Columbia 20010-2970
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Holden Comprehensive Cancer Center at The University of Iowa Iowa City Iowa 52242-1009
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0752
University of Minnesota Cancer Center Minneapolis Minnesota 55455
Mayo Clinic Cancer Center Rochester Minnesota 55905
Children's Mercy Hospital Kansas City Missouri 64108
University of Nebraska Medical Center Omaha Nebraska 68198-3330
Saint Peter's University Hospital New Brunswick New Jersey 08901-1780
NYU School of Medicine's Kaplan Comprehensive Cancer Center New York New York 10016
Memorial Sloan-Kettering Cancer Center New York New York 10021
Mount Sinai School of Medicine New York New York 10029
Herbert Irving Comprehensive Cancer Center New York New York 10032
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Children's Hospital Medical Center - Cincinnati Cincinnati Ohio 45229-3039
Ireland Cancer Center Cleveland Ohio 44106-5065
Children's Hospital of Columbus Columbus Ohio 43205-2696
Doernbecher Children's Hospital Portland Oregon 97201-3098
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-6164

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2013 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002812 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →